Llwytho...

Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention

BACKGROUND: Treatment of symptomatic coronary artery disease with percutaneous intervention requires antithrombotic therapy. Patients with elevated thromboembolic risk benefit from therapy with glycoprotein IIb/IIIa inhibitors. The safety and effectiveness of glycoprotein IIb/IIIa inhibition have be...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Germing, Alfried, Bojara, Waldemar, Lawo, Thomas, Ewers, Aydan, Grewe, Peter, Mügge, Andreas, Lindstaedt, Michael
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Pulsus Group Inc 2010
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954030/
https://ncbi.nlm.nih.gov/pubmed/20959881
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!